Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

benzinga.com/analyst-stock-ratings/downgrades/25/07/46642242/rocket-refocuses-pipeline-as-gene-therapy-sentiment-sours

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a firm focused on developing cardiovascular gene therapy, announced a strategic corporate reorganization to extend its runway.
The restructuring and reprioritization initiative focuses Rocket’s resources on the adeno-associated virus (AAV)…

This story appeared on benzinga.com, 2025-07-25 19:02:47.
The Entire Business World on a Single Page. Free to Use →